Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Cardano Deepens Japan Push With Enterprise Deal

Cardano Deepens Japan Push With Enterprise Deal

DailyCoinDailyCoin2026/10/05 16:24

The Cardano Foundation announced a strategic partnership with Pacific Meta aimed at accelerating blockchain adoption among Japanese companies. The collaboration pairs Cardano’s infrastructure with Pacific Meta’s local market knowledge and enterprise integration experience — a practical setup designed to move projects from pilot talk into live use cases.

What the deal is built to do

In its own framing, the Foundation said the partnership will help Japanese firms “bring real-world blockchain use cases to life.” That is the key distinction.

This is not another abstract ecosystem memorandum. It is positioned as an on-the-ground channel for companies that need both the chain and someone who understands how Japanese enterprises actually buy, integrate, and ship technology.

Pacific Meta’s role is the local bridge: market access, integration support, and the operational layer that often decides whether an enterprise blockchain project stalls or scales. Cardano’s side is the infrastructure and network foundation underneath those deployments.

On The Flipside

  • This partnership does not, by itself, reprice ADA or guarantee immediate transaction volume.
  • But it does add another concrete distribution layer in a market where enterprise credibility counts.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Will the 30-year yield break 6% this month? Economic resilience and inflation pressures drive rates higher, further intensifying the sell-off in US Treasury bonds

U.S. Treasury bonds faced another round of sell-offs on Monday, pushing long-term yields to their highest levels in decades.

智通财经•2026/10/05 23:22

Allegion Buys Overly Door Company

05:37 PM EDT, 10/05/2026 (MT Newswires) -- Allegion (ALLE) said late Monday it has acquired privately held Overly Door Company, a manufacturer of custom specialty doors for acoustic, blast, bullet-resistant and vault security. Overly, based in Greensburg, Pennsylvania, will operate as part of the Allegion Americas segment, it said. Terms of the transaction weren't disclosed.

MT newswire•2026/10/05 21:37

Updated Version 3 - According to the Financial Times, McKesson and CD&R are close to reaching a deal worth more than $5 billion to acquire Option Care.

In the fifth paragraph, a quote from analyst Sahil Pandey was added. Reuters, October 5 - According to the Financial Times, citing informed sources, pharmaceutical distributor McKesson (MCK.N) and private equity firm Clayton Dubilier & Rice are about to reach an acquisition agreement to purchase infusion service provider Option Care Health, with the deal valued (including debt) at over 5 billions USD. After the report was published, Option Care's share price rose by 21% in after-hours trading. The report stated that the deal could be announced as early as Tuesday, but negotiations could still fall through. This potential acquisition would be McKesson’s latest move in expanding its healthcare services portfolio. In August this year, the company agreed to acquire Precision Medicine Group for about 2.25 billions USD (link), as part of its effort over the years to strengthen high-growth business sectors. Leerink Partners analyst Michael Cherny said the “strategic logic” of the deal makes sense, as it would expand McKesson’s business from physician offices to care settings in the home and alternative sites. Option Care provides infusion services that allow patients to receive intravenous treatments at home or other outpatient settings, eliminating the need to go to the hospital. McKesson has previously been restructuring its business portfolio by divesting non-core assets and investing in fields such as oncology and specialty care (link). Driven by the growth of its specialty distribution business and contributions from acquisitions, revenue for its oncology and multi-specialty business segment grew by 33% in the latest fiscal quarter. McKesson declined to comment, while CD&R and Option Care did not immediately respond to Reuters’ requests for comment regarding the report. (For non-English speakers' convenience, Reuters offers automated machine translations of its reports in several languages. As there may be mistakes in the automated translations or some context may not be included, Reuters does not guarantee the accuracy of the automated translation text, which is provided solely for readers’ convenience. Reuters bears no responsibility for any damages or losses caused by the use of automated translation functions.)

路透社•2026/10/05 21:18